Dave Clissold to Speak at Management Forum Conference on Orphan Drug, Regulatory Strategy Matters, and More

Orphan drug exclusivity, FDA regulatory strategies, and advanced therapy products

When

November 29, 2012

Dave Clissold is speaking at the “EU and US Regulatory Issues for IP Professionals” on “Orphan drug exclusivity, FDA regulatory strategies, and advanced therapy products”.

The Rembrandt Hotel

London, England